Search - tctmd.com

Displaying 321 - 340 of 1234

Sort: Relevancy | Date

Presentation TCT 2023

TCT 318: First in Human Tricuspid Valve Replacement Compassionate Use Experience with a Novel Transcatheter Heart Valve Replacement System

Presenter: Jörg Hausleiter

October 25, 2023

Presentation TCT 2023

TCT 260: Tricuspid Regurgitation and Heart Failure: the Fate of Treated vs Untreated in the Percutaneous Era. What is clear now?

Presenter: edoardo zancanaro

October 25, 2023

Presentation TCT 2023

TCT 171: National Estimates for Percentage of All Readmissions With Demographic Features, Length of Stay and Cost Analysis of Transcutaneous vs Open Surgical Tricuspid Valve Interventions

Presenter: Muhammad Khan

October 25, 2023

Presentation TCT 2023

TCT 164: TRILUMINATE eligibility criteria in real-world patients receiving tricuspid valve transcatheter edge-to-edge repair

Presenter: Lukas Stolz

October 25, 2023

Presentation TCT 2023

TCT 673: Outcome and Complication of PCI in Patients with Left Main Disease and Heart Failure in the USA

Presenter: Olayiwola Bolaji

October 25, 2023

Presentation TCT 2023

TCT 149: Severe Pulmonary Artery Hypertension and Rheumatic Disease: Long-Term Follow-UP After Percutaneous Mitral Balloon Commissurotomy

Presenter: Rafael Alexandre Meneguz-Moreno

October 25, 2023

Presentation TCT 2023

Results from the Early Human Experience with the Supira Percutaneous Ventricular Assist Device (Supira Medical)

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

TCT 148: Percutaneous Mitral Balloon Commissurotomy and Restenosis Due to Rheumatic Disease: Single-center Experience

Presenter: Rafael Alexandre Meneguz-Moreno

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS

Presenter: Stephan Windecker

October 24, 2023

Presentation TCT 2023

Management of Aortic Regurgitation in LVAD Patients

Presenter: Lauren Ranard

October 24, 2023

Presentation TCT 2023

Outcomes of TAVR and SAVR in Bicuspid AS: Data From the STS/TVT Registry

Presenter: Tsuyoshi Kaneko

October 24, 2023

Presentation TCT 2023

TAVR Techniques in Bicuspid Anatomy: Valve Selection, Sizing, and Positioning

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

What Should the Interventionist Know About Aortic Regurgitation?

Presenter: Robert Bonow

October 24, 2023

Presentation TCT 2023

CT Guidance for TAVR Planning in Bicuspid AS in 2023

Presenter: Hasan Jilaihawi

October 24, 2023

Presentation TCT 2023

Moderate AS in HFrEF: Time to Treat Is Now

Presenter: Nicolas Van Mieghem

October 24, 2023

Presentation TCT 2023

We Need an RCT, and Here Is How I Would Like to Design It

Presenter: David Cohen

October 24, 2023

Presentation TCT 2023

Case Resolution: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy

Presenter: Vivian Ng

October 24, 2023

Presentation TCT 2023

Index SAVR in Young Patients With Bicuspid AS Is Better for Lifetime Management

Presenter: Basel Ramlawi

October 24, 2023

Advertisement

TCT 318: First in Human Tricuspid Valve Replacement Compassionate Use Experience with a Novel Transcatheter Heart Valve Replacement System

TCT 260: Tricuspid Regurgitation and Heart Failure: the Fate of Treated vs Untreated in the Percutaneous Era. What is clear now?

TCT 171: National Estimates for Percentage of All Readmissions With Demographic Features, Length of Stay and Cost Analysis of Transcutaneous vs Open Surgical Tricuspid Valve Interventions

TCT 164: TRILUMINATE eligibility criteria in real-world patients receiving tricuspid valve transcatheter edge-to-edge repair

TCT 673: Outcome and Complication of PCI in Patients with Left Main Disease and Heart Failure in the USA

TCT 149: Severe Pulmonary Artery Hypertension and Rheumatic Disease: Long-Term Follow-UP After Percutaneous Mitral Balloon Commissurotomy

Results from the Early Human Experience with the Supira Percutaneous Ventricular Assist Device (Supira Medical)

TCT 148: Percutaneous Mitral Balloon Commissurotomy and Restenosis Due to Rheumatic Disease: Single-center Experience

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS

Management of Aortic Regurgitation in LVAD Patients

Outcomes of TAVR and SAVR in Bicuspid AS: Data From the STS/TVT Registry

TAVR Techniques in Bicuspid Anatomy: Valve Selection, Sizing, and Positioning

What Should the Interventionist Know About Aortic Regurgitation?

CT Guidance for TAVR Planning in Bicuspid AS in 2023

Moderate AS in HFrEF: Time to Treat Is Now

We Need an RCT, and Here Is How I Would Like to Design It

Case Resolution: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy

Index SAVR in Young Patients With Bicuspid AS Is Better for Lifetime Management

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content